Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

Is North Korea Now Directly Involved in Combat in Ukraine? General Injured in Airstrike

Daniel Kim Views  

Pyongyang Korean Central News Agency/Yonhap
Pyongyang Korean Central News Agency

A high-ranking North Korean general deployed to the conflict in Ukraine was recently wounded in a Ukrainian airstrike in Russia’s Kursk region, according to a report by The Wall Street Journal on Thursday.

The Wall Street Journal, citing Western officials, provided this information but withheld specific details about the extent of the general’s injuries or his identity.

The strike targeted a Russian government facility in the village of Marino, approximately 20 miles from the front lines, using British-supplied Storm Shadow air-to-ground cruise missiles. This information was based on an analysis of footage from the UK-based Center for Information Resilience (CIR), a non-governmental organization.

The Wall Street Journal referenced a Russian blogger who claimed that several North Korean soldiers were present at the command post of this site, suggesting the North Korean general may have been injured in the attack. The Storm Shadow missile ranges about 155 miles (250 km).

The overall commander of the estimated 11,000 North Korean troops in Ukraine is believed to be Kim Yong Bok, Deputy Chief of Staff and former leader of the 11th Army Corps, a special forces unit known as the “Storm Corps.”

Earlier, Ukrainian President Volodymyr Zelenskyy stated during the European Political Community (EPC) summit in Budapest, Hungary, on November 7 that some North Korean troops stationed in Kursk had engaged in combat, resulting in casualties.

Daniel Kim
content@viewusglobal.com

Comments0

300

Comments0

[DEBATE] Latest Stories

  • Model 3's Struggles: 1 in 4 Fail Safety Inspections in Denmark and Germany
  • Xiaomi’s Success vs. Apple’s Failure: What’s the Difference?
  • Trump Defends Tesla, Promises Action Against Violent Attacks
  • Ford's Bold Move: Will the Mustang Evolve into a Sedan with the Mach 4 Name?
  • Revival of the Estima? Toyota’s Sienna May Re-enter Japan's Market
  • Kia’s EV9 Recalled in the U.S. Over Powertrain Concerns

You May Also Like

  • 1
    FDA Greenlights Sanofi's Qfitlia for Hemophilia—An Innovative Alternative to Daily Injections

    LIFESTYLE 

  • 2
    Prostate Cancer Screenings May Cut Death Risk in Half, Study Finds

    LIFESTYLE 

  • 3
    It’s Not Just Depression: Personality Disorders Linked to Highest Suicide Risk

    LIFESTYLE 

  • 4
    Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout

    LIFESTYLE 

  • 5
    Cutting Carbs? You Might Be Raising Your Risk of Colon Cancer

    LIFESTYLE 

Popular Now

  • 1
    Tired of the Buzz? Fruit and Dairy Might Help, New Study Says

    LIFESTYLE&nbsp

  • 2
    Study Finds Missing Gut Bacteria in Parkinson’s and IBD Patients

    LIFESTYLE&nbsp

  • 3
    New Research Reveals Ketogenic Diet Slows Biological Aging by 6+ Years

    LIFESTYLE&nbsp

  • 4
    New Drug Cuts Heart Disease Risk by 94%—And Has No Major Side Effects

    LIFESTYLE&nbsp

  • 5
    Wegovy Maker Strikes $1B Deal for Next-Gen Obesity Treatment

    LIFESTYLE&nbsp

Must-Reads

  • 1
    FDA Greenlights Sanofi's Qfitlia for Hemophilia—An Innovative Alternative to Daily Injections

    LIFESTYLE 

  • 2
    Prostate Cancer Screenings May Cut Death Risk in Half, Study Finds

    LIFESTYLE 

  • 3
    It’s Not Just Depression: Personality Disorders Linked to Highest Suicide Risk

    LIFESTYLE 

  • 4
    Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout

    LIFESTYLE 

  • 5
    Cutting Carbs? You Might Be Raising Your Risk of Colon Cancer

    LIFESTYLE 

Popular Now

  • 1
    Tired of the Buzz? Fruit and Dairy Might Help, New Study Says

    LIFESTYLE 

  • 2
    Study Finds Missing Gut Bacteria in Parkinson’s and IBD Patients

    LIFESTYLE 

  • 3
    New Research Reveals Ketogenic Diet Slows Biological Aging by 6+ Years

    LIFESTYLE 

  • 4
    New Drug Cuts Heart Disease Risk by 94%—And Has No Major Side Effects

    LIFESTYLE 

  • 5
    Wegovy Maker Strikes $1B Deal for Next-Gen Obesity Treatment

    LIFESTYLE